SCHEMBL28523948

SCHEMBL28523948

CS(=O)(=O)c1ccc(NC(=O)C2CC2C(=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 1/20 0.50
KMT2A Q03164 5/20 0.49
MEN1 O00255 3/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
KDM4E B2RXH2 1/20 0.49
HTT P42858 1/20 0.49
TGM2 P21980 1/20 0.49
SCN3A Q9NY46 1/20 0.48
PARP1 P09874 1/20 0.48
PARP10 Q53GL7 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
PKM P14618 1/20 0.46
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15331088 0.78 SMN1; SMN2 (0.55) KMT2AMEN1LMNASMN1; SMN2KDM4E
SCHEMBL10768094 0.78 RAB9A (0.71) KMT2AMEN1LMNASMN1; SMN2KDM4E
SCHEMBL28508124 0.78 LMNA (0.54) KMT2AMEN1LMNASMN1; SMN2KDM4E
SCHEMBL1240947 0.75 LMNA (0.66) KMT2AMEN1LMNASMN1; SMN2HTT
SCHEMBL11526389 0.75 TGM2 (0.62) TGM2NPC1RAB9APKM
SCHEMBL13927087 0.74 PARP1 (0.49) KMT2AMEN1LMNASMN1; SMN2KDM4E
SCHEMBL3917825 0.74 EPHX2 (0.54) KMT2AMEN1LMNASMN1; SMN2KDM4E
SCHEMBL13927084 0.74 PARP1 (0.49) KMT2AMEN1LMNASMN1; SMN2KDM4E
SCHEMBL28668472 0.74 SMN1; SMN2 (0.48) KMT2AMEN1SMN1; SMN2KDM4EHTT
SCHEMBL6972945 0.74 PARP1 (0.49) KMT2AMEN1LMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108503650-B Dioxane and quinazoline compound or medicinal salt or hydrate thereof and application of dioxane and quinazoline compound or medicinal salt or hydrate thereof as tyrosine kinase inhibitor 北京赛特明强医药科技有限公司 2021-02-12 CN disclosed